Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment

At JADPRO Live 2019, Krista M. Rubin, MS, FNP-BC, and Anthony J. Olszanski, MD, RPh, reviewed the basic concepts of immunotherapy and the current treatment landscape, and discussed emerging data for immune checkpoint inhibitor–based combinations that are being explored in late-stage clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, Krista M., Olszanski, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857323/
https://www.ncbi.nlm.nih.gov/pubmed/33598316
http://dx.doi.org/10.6004/jadpro.2020.11.3.3
_version_ 1783646425467322368
author Rubin, Krista M.
Olszanski, Anthony J.
author_facet Rubin, Krista M.
Olszanski, Anthony J.
author_sort Rubin, Krista M.
collection PubMed
description At JADPRO Live 2019, Krista M. Rubin, MS, FNP-BC, and Anthony J. Olszanski, MD, RPh, reviewed the basic concepts of immunotherapy and the current treatment landscape, and discussed emerging data for immune checkpoint inhibitor–based combinations that are being explored in late-stage clinical trials.
format Online
Article
Text
id pubmed-7857323
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-78573232021-02-16 Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment Rubin, Krista M. Olszanski, Anthony J. J Adv Pract Oncol Meeting Reports At JADPRO Live 2019, Krista M. Rubin, MS, FNP-BC, and Anthony J. Olszanski, MD, RPh, reviewed the basic concepts of immunotherapy and the current treatment landscape, and discussed emerging data for immune checkpoint inhibitor–based combinations that are being explored in late-stage clinical trials. Harborside Press LLC 2020-04 2020-04-01 /pmc/articles/PMC7857323/ /pubmed/33598316 http://dx.doi.org/10.6004/jadpro.2020.11.3.3 Text en © 2020 Harborside™ http://creativecommons.org/licenses/by-nc-nd/3.0/ This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Rubin, Krista M.
Olszanski, Anthony J.
Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
title Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
title_full Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
title_fullStr Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
title_full_unstemmed Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
title_short Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment
title_sort immune checkpoint inhibitor–based therapy as a backbone in cancer treatment
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857323/
https://www.ncbi.nlm.nih.gov/pubmed/33598316
http://dx.doi.org/10.6004/jadpro.2020.11.3.3
work_keys_str_mv AT rubinkristam immunecheckpointinhibitorbasedtherapyasabackboneincancertreatment
AT olszanskianthonyj immunecheckpointinhibitorbasedtherapyasabackboneincancertreatment

Ejemplares similares